It was recently revealed that the Department of Health and Human Services has entered into a contract with a New York based corporation called Siga Technologies. You the taxpayer, will pay Siga $443 million, and, in return, Siga will supply “an experimental remedy for a threat that may not exist”. And, were that not enough, Siga was the only company allowed to bid on this contract.
Under the contract, Siga will provide 1.7 million doses of an anti-viral pill known as ST-246 for “only” $255 per dose. The pill is supossed to treat small pox. Of course, the federal government already has $1 billion supply of small pox vacine which cost the federal government a whopping $3 per dose.
Here is how this arrangement happened.
When Siga complained that contracting specialists at the Department of Health and Human Services were resisting the company’s financial demands, senior officials replaced the government’s lead negotiator for the deal, interviews and documents show.
When Siga was in danger of losing its grip on the contract a year ago, the officials blocked other firms from competing. [emphasis supplied]
And, were that not enough,
The price of approximately $255 per dose is well above what the government’s specialists had earlier said was reasonable, according to internal documents and interviews. [emphasis supplied]
But the worst part is we don’t even know if this drug will work. Small pox was eradicated world wide in 1978, so, there is no one on whom to test the drug, and, even if it is tested on animals, scientists cannot say that the drug will have the same effect on humans.
I almost forgot…Siga’s largest shareholder is none other than Ronald O. Perleman, a long time Democratic Party donor.